Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

Medtronic announced the first U.S. commercial cases for its Hugo soft-tissue robotic surgery system, conducted at Cleveland ...

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Medtronic competes with Abbott and Dexcom in continuous glucose ⁠monitoring, a market that has expanded as patients increasingly adopt convenient finger prick-free technologies to track glucose levels ...

Exercising option to acquire will bolster Medtronic's interventional cardiology portfolio, expanding its leadership in transforming how cardiovascular disease is diagnosed and treated Medtronic's ...

GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and ...

The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.

On February 2, 2026, Medtronic announced three new developments for the company’s 780G automated insulin-delivery (AID) system — cleared for use last year by the US FDA in type 2 diabetes (T2D) — ...

GALWAY, Ireland - Medtronic (NYSE:MDT) announced three key milestones for its MiniMed 780G automated insulin delivery system on Monday, expanding options for people with diabetes in the United States.

Danaher to buy Masimo in $9.9 billion deal in diagnostics push Danaher will acquire Masimo in a $9.9 billion deal, as it looks to expand its diagnostics portfolio with the California-based medtech ...

Investment firm Stonepeak has struck a deal with the French shipping company CMA CGM to create a U.S.-based port venture valued at around $10 billion. The duo aims to accelerate investments in new ...